home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

199 rows where filing_period = "second_quarter", filing_year = 2010 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 199 ✖

filing_year 1

  • 2010 · 199 ✖

filing_period 1

  • second_quarter · 199 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
946814 HOLLAND & KNIGHT LLP 6ef5ef96-3574-4f95-bd57-02bfdb1eebb8 Q2 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2010 second_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2010-06-29T13:22:49.667000-04:00
946820 HOLLAND & KNIGHT LLP d67793e3-bf4d-4bbd-9971-337eb79870ea Q2 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2010 second_quarter PHA Blood and blood product safety; issues related to blood product approvals; Healthcare Reform legislation-340B program and orphan drugs.. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2010-06-29T13:27:54.447000-04:00
947159 CYBER SECURITY RESEARCH CONSULTANTS, LLC 511f60a4-2eaa-46c2-8e08-3d9df26882d9 Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2010 second_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-01T19:16:56.360000-04:00
947477 LONG TERM CARE PHARMACY ALLIANCE 57ed45af-97c0-46ad-a0a6-f0130d24a5a8 Q2 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2010 second_quarter PHA Medicare Part D Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   125000 0 0 2010-07-06T11:28:09.923000-04:00
947574 MR. THEODORE (TED) JONES c765622d-e579-430e-9c45-b5c74e64ae9f Q2 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2010 second_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-06T14:16:37.477000-04:00
947627 NAHIGIAN STRATEGIES, LLC feeccad0-bb1b-4aa0-b503-6ac94e5763bb Q2 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2010 second_quarter PHA Issues pertaining to generic pharmaceuticals HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-06T16:16:04.557000-04:00
947929 AMERICAN COLLEGE OF CLINICAL PHARMACY d58de490-c00e-4e6b-a11d-d2322c7f8ab8 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2010 second_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   54750 0 0 2010-07-07T15:29:08.027000-04:00
947938 HANCE SCARBOROUGH a961ee44-93b8-444a-951e-a917afbdd519 Q2 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2010 second_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-07T15:39:05.630000-04:00
947949 HANCE SCARBOROUGH 4be36a2e-e651-4c4d-bbc7-55b08c6f5943 Q2 HANCE SCARBOROUGH 17443 TEXAS ACADEMY OF COMPOUNDING PHARMACISTS 2010 second_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-07T15:54:11.083000-04:00
949157 GREATER NEW YORK HOSPITAL ASSOCIATION c13e4b83-81c6-4543-939f-f7b25851228e Q2 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2010 second_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590, P.L. 111-148; H.R.4872, P.L. 111-152); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239); H.R.4213) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   420000 0 0 2010-07-09T15:01:48.987000-04:00
949367 WINBORN SOLUTIONS LLC 8da22e6a-74d1-4d12-b8bd-f836685e2044 Q2 WINBORN SOLUTIONS LLC 308310 PERRIGO CO 2010 second_quarter PHA Dextromethorphan Distribution Act of 2009 Legislation to regulate the sale of psuedoephedrine Food and drug safety, user fee, and country of origin legislation HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2010-07-10T20:23:21.673000-04:00
949482 SQUIRE PATTON BOGGS 3da19257-15ff-478f-8f17-8c1cf20d53f4 Q2 SQUIRE PATTON BOGGS 30906 KERR CORPORATION 2010 second_quarter PHA Issues related to FDA enforcement action against counterfeit medical devices. HOUSE OF REPRESENTATIVES     0 0 2010-07-12T08:37:58.520000-04:00
950227 ASSOCIATION OF NATIONAL ADVERTISERS, INC. ee12142b-bfa8-481b-9d85-e1d1c4db0f63 Q2 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2010 second_quarter PHA Proposals to place a moratorium on prescription drug advertising and requiring a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to extend FDA authority to over-the-counter drug advertisements FDA proposed rule to implement requirements for "major statement" in DTC television or radio ads H.R. 2175 - Families for ED Decency Act, to prohibit the broadcast of drugs for erectile dysfuncton/male enhancement on indecency grounds Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2010-07-12T17:03:51.513000-04:00
950449 VENABLE LLP c7e7c9bc-8274-4fa2-943b-bd14faf5ecfc Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2010 second_quarter PHA General issues affecting the pharmaceutical industry HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2010-07-13T09:17:15.203000-04:00
950853 LOCKE LORD PUBLIC POLICY GROUP LLC ca047eaa-69a4-43f5-b17a-8b441b11e4c9 Q2 LOCKE LORD PUBLIC POLICY GROUP LLC 300971 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2010 second_quarter PHA Pharmceutical performance reimbursement; biogenics HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-07-13T11:54:26.030000-04:00
951437 MEREDITH MCGEHEE 883146c8-8d38-4d09-961a-aef2ba090c82 Q2 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2010 second_quarter PHA Funding for programs to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to education on research and development programs aimed at the AIDS epidemic and other health issues; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on IAVI's Antibody Project and PDP model; Providing input on foreign assistance reform from a global health perspective HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-13T14:41:47.327000-04:00
952760 DUTKO WORLDWIDE, LLC dab1145e-09a5-4787-805d-2ad1b25a1f64 Q2 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2010 second_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-14T13:04:02.807000-04:00
953194 POLICY DIRECTIONS INC. 81672818-f1a3-4794-bad4-856dab98b6e6 Q2 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2010 second_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-14T15:26:40.213000-04:00
953248 PARRY, ROMANI, DECONCINI & SYMMS a433eeab-5d9d-4703-b796-705e25e4c6ad Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AMGEN USA INC. 2010 second_quarter PHA No specific issues or legislation during this reporting period.   45000   0 0 2010-07-14T15:33:56.683000-04:00
953679 CAPITOL HILL CONSULTING GROUP dd550b8e-9fc9-4a6e-964a-e17e0489b31e Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2010 second_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-14T18:43:52.573000-04:00
953895 JULIE PHILP 2a109346-86e0-4a5b-9e1b-b7417246ec5c Q2 JULIE PHILP 400407928 NATIONAL GRASSROOTS AND COMMUNICATION 2010 second_quarter PHA Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescription drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health plans; and create a fund to pay for prescription medicines for low-income individuals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-15T10:02:37.497000-04:00
953915 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK f6e16e48-0063-452d-8971-60e3471910f5 Q2 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2010 second_quarter PHA Support legislation (HR 1204) to allow independent pharmacists to collectively negotiate contracts with prescrption drug plans and health insurance plans. Support legislation (HR 4199) to define pharmacists as health care providers under Medicare; increase dispensing fees for pharmacies; eliminate spread pricing; return rebates to health care plans; and create a fund for prescription medicines for low-income individuals. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-15T10:14:42.247000-04:00
954289 AMERICAN ADVERTISING FEDERATION 25ae56da-e605-4d3c-baa0-f5f6688b8557 Q2 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2010 second_quarter PHA Hr 3200, HR 3590, S 1679, S 1796, health care reform legislation as it affects the taxation or content of pharmaceutical advertising HR 2175, to prohibit as indecent the broadcasting of any advertisement for a medication for the treatment of erectile dysfunction Proposals to require a moratorium on the advertising of new prescription medications Proposals to extend Food and Drug Administration authority to advertising for over-the-counter medications Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2010-07-15T11:51:32.467000-04:00
954666 PARRY, ROMANI, DECONCINI & SYMMS ff8eb4b6-07da-4bb3-b2e7-426e172b5e50 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2010 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T13:42:33.073000-04:00
954686 THE OB-C GROUP, LLC 1cd91d3a-4d90-4358-9e4a-5f84281f7ec9 Q2 THE OB-C GROUP, LLC 29802 ELI LILLY 2010 second_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-15T13:45:50.837000-04:00
954756 PARRY, ROMANI, DECONCINI & SYMMS 831cb22b-4b9e-4a79-8680-28bb40ebc165 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2010 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T14:00:06.603000-04:00
954825 PARRY, ROMANI, DECONCINI & SYMMS a7ec478c-527a-4edd-89ef-cdcd59d0ce29 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2010 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018 and S. 3274, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T14:16:32.360000-04:00
955021 VAN NESS FELDMAN, LLP efcff0d1-b57e-44e4-99de-57c1784fd503 Q2 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2010 second_quarter PHA H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-15T15:24:35.350000-04:00
955099 PARRY, ROMANI, DECONCINI & SYMMS 4cc586da-bc2c-41cc-bed8-dbc8307055d0 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2010 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2010-07-15T15:53:07.367000-04:00
955237 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS d597a90a-98f2-49cf-b272-f5843a4fd4e0 Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2010 second_quarter PHA Communications with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act reauthorization; communication with Office of Pharmacy Affairs, Health Resources and Services Administration on 340B drug pricing program, transition to new Director of Office of Pharmacy Affairs, Patient Safety and Clinical Services Collaborative, status of patient definition guidelines, increased federal funds for community health centers, National Healthcare Workforce Commission; Commmunication with FDA on distribution of medication guides in the inpatient setting; communication with FDA on drug recalls; communication with DEA on electronic prescriptions for controlled substances; meeting with HRSA's Office of Rural Health Policy to discuss medication therapy management, workforce commission, patient safety collaborative, telepharmacy, 340B and health IT. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2010-07-15T16:21:06.503000-04:00
955262 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 6684c130-7564-43f6-b398-8272ef839e16 Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2010 second_quarter PHA Importation of prescription drugs (S.525/H.R. 1298); Import Safety (H.R. 759); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues - (H.R. 4489); Drug Disposal Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   220000 0 0 2010-07-15T16:28:41.117000-04:00
955755 INDEPENDENT PHARMACY COOPERATIVE 102a3236-7c53-4370-b2fe-3ef0162431ec Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2010 second_quarter PHA H.R. 3590 Patient Protection and Affordable Care Act specifically Average Manufacturer Price Pharmacy Reimbursement H.R. 3590 DMEPOS Pharmacy Accreditation H.R. 3590 PBM Transparency in Health Insurance "Exchanges" H.R. 3590 H.R. 5235, Medicare Access to Diabetes Supplies Act. H.R. 3790 Repeal DMEPOS Competitive Bidding H.R. 5234 The PBM Audit and Transparency Act of 2010 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2010-07-15T19:21:59.553000-04:00
955805 NOVO NORDISK INC. a8c113f2-4499-4582-bfdf-890115a99d31 Q2 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2010 second_quarter PHA H.R. 1, American Recovery and Reinvestment Act of 2009, H. Con. Res. 85, S. Con. Res. 13, and H.R. 4851, Continuing Extension Act of 2010; issues regarding comparative effectiveness Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE   375000 0 0 2010-07-15T20:32:29.363000-04:00
956342 UNIVERSITY OF CONNECTICUT a592281b-9114-4073-95c4-cf69a58d3cb3 Q2 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2010 second_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA Salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)   70000 0 0 2010-07-16T10:51:57.813000-04:00
958339 TEVA PHARMACEUTICALS USA, INC. 755075ce-f55a-4c16-a45d-ed074459fbad Q2 TEVA PHARMACEUTICALS USA, INC. 76695 TEVA PHARMACEUTICALS USA INC 2010 second_quarter PHA H.R. 1859 & S. 767, Independent Drug Education & Outreach Act of 2009; Proposals relating to the "doughnut hole" impact; and implementation of healthcare reform legislation. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Customs & Border Protection,U.S. Trade Representative (USTR)   840000 0 0 2010-07-16T17:19:21.280000-04:00
958395 UNIVERSITY OF IOWA 248299ff-f28d-4553-b042-d5c12fbd8c35 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2010 second_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   110000 0 0 2010-07-16T17:28:41.297000-04:00
959396 SQUIRE PATTON BOGGS a172d394-66ae-414d-a573-1a27005f24a7 Q2 SQUIRE PATTON BOGGS 30906 SUNOVION PHARMACEUTICALS INC 2010 second_quarter PHA Issues related to respiratory drug coverage and H.R. 3590. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-18T05:31:48.253000-04:00
959783 APOTEX CORP. d85bcb74-6daa-4d6a-8eb7-3e31c69ab168 Q2 APOTEX CORP. 310973 APOTEX CORP. 2010 second_quarter PHA S. 1315/HR 3777 the Drug Price Competition Act of 2009 S. 369, the Preserve Access to Affordable Generics Act HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2, Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements HR 759, Food and Drug Administration Globalization Act of 2009 Pharmaceutical waste disposal Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2010-07-18T22:08:46.433000-04:00
959793 MCDERMOTT WILL & SCHULTE LLP 8edd6131-8b45-4258-a6ea-0dc49ac38084 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2010 second_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2010-07-18T22:19:54.593000-04:00
959808 MCDERMOTT WILL & SCHULTE LLP d6692f0d-b60a-478a-aa28-b91864dbd27f Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2010 second_quarter PHA Issues related to Section 340B of the Public Health Service Act. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-18T22:46:02.453000-04:00
959829 MCDERMOTT WILL & SCHULTE LLP d9d04307-e7a1-4430-9ff5-8efc5deacbdd Q2 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2010 second_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2010-07-18T23:28:17.137000-04:00
960214 VAN SCOYOC ASSOCIATES af0fe7df-54a7-4a76-a2a4-eef479b5d5e6 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2010 second_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) 50000   0 0 2010-07-19T06:57:21.357000-04:00
960221 VAN SCOYOC ASSOCIATES 8f2b3b00-fb25-43b8-afb6-a4f552a7a198 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2010 second_quarter PHA Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-19T06:58:23.540000-04:00
960292 SANOFI US SERVICES INC. e00f6d61-2c00-4ee3-87d0-2b1efe2a1c30 Q2 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2010 second_quarter PHA Issues related to the TRICARE retail rebate program; issues related to the 340B Federal Drug Pricing Program Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   870000 0 0 2010-07-19T09:01:39.050000-04:00
960305 EISAI INC. 4657efed-4f99-4c23-a1a7-46b0c5bf262b Q2 EISAI INC. 400321512 EISAI INC. 2010 second_quarter PHA biosimilars, follow-on biologics S 726 Promoting Innovation and Access to Life-Saving Medicine Act HR 3590 Patient Protection and Affordable Care Act HR 4872 Health Care and Education Reconciliation Act of 2010 HOUSE OF REPRESENTATIVES,SENATE   1060000 0 0 2010-07-19T09:07:45.277000-04:00
960489 AKIN GUMP STRAUSS HAUER & FELD 09d38b09-29ac-46e9-9446-62fec36de603 Q2 AKIN GUMP STRAUSS HAUER & FELD 682 PRASCO, INC. 2010 second_quarter PHA Promoting consumer benefits of authorized generic drugs Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-19T09:52:42.163000-04:00
960902 AMERICAN VETERINARY MEDICAL ASSOCIATION 69d870ac-b3ce-48cf-b1f5-9f5eb6d0071b Q2 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2010 second_quarter PHA HR 1549/S 619, Preservation of Antibiotics for Medical Treatment Act HR 2400, Strategies to Address Antimicorbial Resistance (STAAR) Act Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   110000 0 0 2010-07-19T10:57:56.953000-04:00
961172 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 6d90bbd7-901c-4a97-9f66-6340f033f372 Q2 WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC 41113 JARROW FORMULAS, INC. 2010 second_quarter PHA Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; S. 510 and the Dietary Supplement Health and Education Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-19T11:23:55.780000-04:00
961694 THE DUBERSTEIN GROUP INC. 90782503-1dcf-4071-a247-9997dc55b452 Q2 THE DUBERSTEIN GROUP INC. 12675 AMERICA'S HEALTH INSURANCE PLANS 2010 second_quarter PHA *Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009. *Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act. *Generic biologics - HR 3590, Patient Protection and Affordable Care Act. *Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009. HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 100000   0 0 2010-07-19T12:12:35.030000-04:00
961717 GREENBERG TRAURIG, LLP bd064733-b756-45ae-b840-3f683e16c114 Q2 GREENBERG TRAURIG, LLP 16896 RICHIE & GUERINGER, P.C. 2010 second_quarter PHA Congressional actions on health care reform. HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-19T12:14:43.620000-04:00
961884 THE DUBERSTEIN GROUP INC. 58738edf-6eb7-4493-84b4-6e65fee071b1 Q2 THE DUBERSTEIN GROUP INC. 12675 NORVARTIS CORP 2010 second_quarter PHA Pandemic funding - HR 4899, Supplemental Appropriations Act, 2010. SENATE 100000   0 0 2010-07-19T12:33:56.753000-04:00
962328 SMITH GARSON FKA SMITH DAWSON & ANDREWS 1b0141a2-8faf-4f94-b3b2-8a27e6feb600 Q2 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 PROSETTA CORPORATION 2010 second_quarter PHA Government Advertisement of Biopharmaceuticals SENATE 7500   0 0 2010-07-19T13:25:23.957000-04:00
962445 SMITH GARSON FKA SMITH DAWSON & ANDREWS dffa6c27-f572-43aa-a040-373f7026d119 Q2 SMITH GARSON FKA SMITH DAWSON & ANDREWS 35707 STRUVE SWINE TECHNOLOGIES 2010 second_quarter PHA Government Advertisement of Biopharmaceuticals SENATE     0 0 2010-07-19T13:36:07.817000-04:00
962450 GREENBERG TRAURIG, LLP 4c58f2a2-1821-46ba-bdca-124127016b76 Q2 GREENBERG TRAURIG, LLP 16896 GENERIC PHARMACEUTICAL ASSOCIATION 2010 second_quarter PHA Representation on international trade issues affecting generic pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) 10000   0 0 2010-07-19T13:37:09.117000-04:00
962841 EVERTZ GROUP LLC 5cf0d963-3868-4088-99ea-9e1fb782e6d5 Q2 EVERTZ GROUP LLC 400497446 MYLAN INC. 2010 second_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2010-07-19T14:05:14.583000-04:00
963163 TARPLIN STRATEGIES LLC 4781f20d-1077-4e7b-bdd0-e275c4ae1e57 Q2 TARPLIN STRATEGIES LLC 40032282 GENENTECH, INC. 2010 second_quarter PHA Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to FDA approval of follow-on biologics and length of data exclusivity period, 340B drug pricing program, structure of the Medicare prescription drug benefit. H.R. 4213, the American Jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes related to the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program. Public Law 111-152, the Health Care and Education Reconciliation Act of 2010 - Implementation issues related to Medicare and Medicaid reimbursement, fees assessed on the pharmaceutical industry, design and structure of the Medicare prescription drug benefit. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2010-07-19T14:28:29.987000-04:00
963218 FOLEY & LARDNER LLP 1afdc158-a86f-4727-b334-2f89898a4854 Q2 FOLEY & LARDNER LLP 15042 ROMARK LABORATORIES, LC 2010 second_quarter PHA Sale of new anti-viral drug Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-19T14:32:28.127000-04:00
963223 APOTEX CORP. f1097175-4378-42b4-a3aa-66c9ff69a820 Q2 APOTEX CORP. 310973 APOTEX CORP. 2010 second_quarter PHA S. 1315/HR 3777 the Drug Price Competition Act of 2009 S. 369, the Preserve Access to Affordable Generics Act HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2, Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements HR 759, Food and Drug Administration Globalization Act of 2009 Pharmaceutical waste disposal Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2010-07-19T14:32:30.363000-04:00
963308 AARP fdee0cf1-7480-41a1-b928-035e0a8307d3 Q2 AARP 1694 AARP 2010 second_quarter PHA S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide qualit… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   4250000 0 0 2010-07-19T14:38:48.247000-04:00
963444 APOTEX CORP. 112a7cc6-7ff3-481b-a5e1-2f32634d6cf7 2A APOTEX CORP. 310973 APOTEX CORP. 2010 second_quarter PHA S. 1315/HR 3777 the Drug Price Competition Act of 2009 S. 369, the Preserve Access to Affordable Generics Act HR 4899 EAH, Supplemental Disaster Relief and Summer Jobs Act of 2010, Chapter 2, Section 4201, Preserve Access to Affordable Generics Act SA 4361 to HR 4213 concerning market blockages caused by pharmaceutical patent settlements HR 759, Food and Drug Administration Globalization Act of 2009 Pharmaceutical waste disposal Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2010-07-19T14:48:52.140000-04:00
963497 AARP 45b30691-7cda-4d65-be91-929994b9a54e 2A AARP 1694 AARP 2010 second_quarter PHA S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide qualit… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   4250000 0 0 2010-07-19T14:52:11.133000-04:00
963825 PODESTA GROUP, INC. de1ae31f-5e4c-45f6-827c-76f2376fa07e Q2 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2010 second_quarter PHA Drug Importation/Drug Safety H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-19T15:14:25.977000-04:00
963930 PODESTA GROUP, INC. a8d09995-9922-43da-8fa4-3db52392ab9b Q2 PODESTA GROUP, INC. 31680 CUBIST PHARMACEUTICALS INC 2010 second_quarter PHA Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act S. 369 Preserve Access to Affordable Generics Act of 2009 Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-07-19T15:21:01.417000-04:00
964167 PODESTA GROUP, INC. 665a1c72-a2cd-45cb-8d2a-cb20ed7273c2 Q2 PODESTA GROUP, INC. 31680 EISAI INC. 2010 second_quarter PHA S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2010-07-19T15:33:18.283000-04:00
964251 PODESTA GROUP, INC. af035938-25e7-4700-90be-383a073f3624 Q2 PODESTA GROUP, INC. 31680 MILLENNIUM PHARMACEUTICALS INC 2010 second_quarter PHA S. 717 21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-19T15:36:41.090000-04:00
964366 PODESTA GROUP, INC. da4b40e8-9f82-445d-8f8a-9448ab517305 Q2 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2010 second_quarter PHA Drug Importation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 60000   0 0 2010-07-19T15:42:20.030000-04:00
964415 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 20424092-e58a-44b9-8032-7183db49f59c Q2 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2010 second_quarter PHA Health Care Reform Law Implementation Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   740000 0 0 2010-07-19T15:44:38.637000-04:00
964539 WINSTON & STRAWN LLP 1f3b2cc1-7ebd-4fbf-85a3-10264209a9c8 Q2 WINSTON & STRAWN LLP 41682 TEVA PHARMACEUTICALS USA 2010 second_quarter PHA Biogenerics HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-19T15:51:16.433000-04:00
964762 WINSTON & STRAWN LLP 46e9accf-60a9-4be9-9fad-1437c5145b3d Q2 WINSTON & STRAWN LLP 41682 WOCKHARDT USA LLC 2010 second_quarter PHA Generic drug issues - preemption; FTC settlements HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2010-07-19T16:03:41.357000-04:00
964816 UNIVERSITY OF KANSAS e42ce731-7548-4405-a5ce-22c7a5fcbd2a Q2 UNIVERSITY OF KANSAS 321373 UNIVERSITY OF KANSAS 2010 second_quarter PHA Briefing on nanotechnology research for inhaled pharmaceuticals and applicaiton for chemical, biological, radiation, and nuclear responses. Requested statement for congressional hearing related to the University of Kansas and its pharmaceutical research program in neglected and rare diseases. Army, Dept of (Other),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,White House Office   47500 0 0 2010-07-19T16:07:05.837000-04:00
964901 CVS HEALTH (AND SUBSIDIARIES) 2078b7ea-8035-4b8f-8b57-75ba6f85ca01 Q2 CVS HEALTH (AND SUBSIDIARIES) 302778 CVS CAREMARK INC 2010 second_quarter PHA Pharmacy Issues related to drug safety and the tracking of drug suppliers. HOUSE OF REPRESENTATIVES,SENATE   2250000 0 0 2010-07-19T16:12:33.443000-04:00
965190 EXPRESS SCRIPTS, INC. a5206338-c3a2-44c2-a9ac-0b5609351772 Q2 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2010 second_quarter PHA Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 HR 5234, PBM Audit Reform and Transparency Act Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   410000 0 0 2010-07-19T16:36:01.303000-04:00
965385 OREGON HEALTH & SCIENCE UNIVERSITY 6b00fd4f-70b1-4d13-96e9-84273c2eda79 Q2 OREGON HEALTH & SCIENCE UNIVERSITY 30291 OREGON HEALTH & SCIENCE UNIVERSITY 2010 second_quarter PHA Discounted Drug Prices for 340B Hospitals: Section 340B of the Public Health Services Act (HR 444/S 1239); American Jobs and Closing Tax Loopholes Act of 2010 (HR 4213). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Vice President of the U.S.   90000 0 0 2010-07-19T16:49:10.460000-04:00
965412 WINSTON & STRAWN LLP ad18a2b0-991c-4e6f-af10-683e9396aa3e Q2 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2010 second_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-19T16:52:21.267000-04:00
965469 AMYLIN PHARMACEUTICALS 3446857a-880a-4211-a214-8e58e0ee530d Q2 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2010 second_quarter PHA Physician Payments Sunshine provision of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010) FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2010-07-19T16:57:15.527000-04:00
965508 MEHLMAN CONSULTING, INC. 310d5fbf-dbd5-4937-987a-44cd0f5c20a9 Q2 MEHLMAN CONSULTING, INC. 284950 MERCK AND CO INC 2010 second_quarter PHA Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-19T17:02:03.960000-04:00
965512 ACADEMY OF MANAGED CARE PHARMACY d8044c76-bfdb-4c03-8ed3-725348fa4406 Q2 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2010 second_quarter PHA Legislation relating to to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs and funding for said programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally. HOUSE OF REPRESENTATIVES,SENATE   155000 0 0 2010-07-19T17:02:24.017000-04:00
965712 AMERICAN HEALTH CARE ASSOCIATION 40e5611a-03d5-4a78-a62e-765edd35578a Q2 AMERICAN HEALTH CARE ASSOCIATION 2491 AMERICAN HEALTH CARE ASSOCIATION 2010 second_quarter PHA Updating controlled sustances regulations for long-term care. S.3397: Secure and Responsible Drug Disposal Act of 2010. Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE   480000 0 0 2010-07-19T17:16:00.397000-04:00
965821 VAN SCOYOC ASSOCIATES 804b9495-d9ad-4a66-af94-dfab6b477601 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2010 second_quarter PHA No lobbying activity. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-19T17:26:40.377000-04:00
966741 KAISER FOUNDATION HEALTH PLAN INC. a306523f-dfb0-4df9-b161-d7516341ca55 Q2 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2010 second_quarter PHA S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   140000 0 0 2010-07-19T19:39:49.010000-04:00
966842 POLICY ADVOCATES f578c8bb-b46a-43e4-bb28-a06ff83f6605 2T POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2010 second_quarter PHA Track and monitor Internet Pharmacy Issues. HOUSE OF REPRESENTATIVES,SENATE 13500   0 1 2010-07-19T20:16:22.970000-04:00
966922 WALMART INC. a701d91e-28b6-4fdb-a767-e5f91971bf5f Q2 WALMART INC. 40305 WALMART INC 2010 second_quarter PHA H.R. 5234, PBM Audit Reform and Transparency Act of 2010, to ensure transparency and proper operation of pharmacy benefit managers Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Federal Highway Administration (FHA),Federal Motor Carrier Safety Administration,Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Labor, Dept of (DOL),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR),White House Office   1430000 0 0 2010-07-19T20:42:12.890000-04:00
967069 OGR cc56e002-e8f9-43e3-af5e-0bfd63558e6e Q2 OGR 48827 SANOFI PASTEUR 2010 second_quarter PHA vaccine related issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-19T22:08:45.803000-04:00
967114 PODESTA GROUP, INC. ed63e2a4-f148-4cf0-a459-f7e539ca47a5 Q2 PODESTA GROUP, INC. 31680 GENZYME 2010 second_quarter PHA H.R. 3156 Neglected Disease Tax Credit Bill H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2010-07-19T22:46:06.730000-04:00
967582 ACG ADVOCACY 81113808-f3a1-4b80-bc6c-870a533d93c4 Q2 ACG ADVOCACY 2057 PFIZER, INC. 2010 second_quarter PHA Followon Biologics Super MedPAC HRSA - 340B Drug Pricing Program/Pharmacy Affairs HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2010-07-20T07:26:33.593000-04:00
967671 INDEPENDENCE BLUE CROSS f1168b53-20d0-498a-af93-4dd32eac1fd1 Q2 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2010 second_quarter PHA HR 4489 "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act"; Pharmacy Antitrust pharmacy antitrust issues HOUSE OF REPRESENTATIVES,SENATE     0 0 2010-07-20T08:06:03.887000-04:00
967680 RUBICON ADVISORS, LLC aea864e0-cc69-4378-b751-e417b79926ee Q2 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2010 second_quarter PHA Patent Settlements H.R. 1432, Genetic Biologics S. H.R. 1695, H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affordable Health Choices Act   105000   0 0 2010-07-20T08:15:17.553000-04:00
967702 RUBICON ADVISORS, LLC d396a0f9-3300-475b-9fc5-53981deaa097 Q2 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2010 second_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S. 316 Generic Biologics S. 1685 H.R. 5629 Physician Payment Sunshine Act S. 2029   98000   0 0 2010-07-20T08:19:26.593000-04:00
967730 RUBICON ADVISORS, LLC 1985a83c-dee6-417b-be83-194ed30305a3 Q2 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2010 second_quarter PHA Physiciam Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act   30000   0 0 2010-07-20T08:24:33.010000-04:00
967743 U.S. CHAMBER INSTITUTE FOR LEGAL REFORM 00c2451f-6408-405d-b475-99360e2f83c5 Q2 U.S. CHAMBER INSTITUTE FOR LEGAL REFORM 51172 U S CHAMBER INSTITUTE FOR LEGAL REFORM 2010 second_quarter PHA S. 540/H.R. 1346, Medical Device Safety Act of 2009 General background on drug and device labeling rules and the doctrine of Federal preemption (no specific legislation introduced) HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Securities & Exchange Commission (SEC),SENATE   3750000 0 0 2010-07-20T08:27:31.987000-04:00
967766 RUBICON ADVISORS, LLC 24a48d4d-b862-47a9-84eb-fb697e2ebf76 Q2 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2010 second_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2010-07-20T08:28:40.520000-04:00
967775 RUBICON ADVISORS, LLC bc90051a-23a1-4e1a-a563-b58cfaea94dd Q2 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2010 second_quarter PHA Generic Biologics S. 1695 Affordable Health Care Choices Act   22500   0 0 2010-07-20T08:32:46.347000-04:00
967815 CHAMBER OF COMMERCE OF THE U.S.A. 09c9209f-c561-47aa-8fd7-af9e36b58890 Q2 CHAMBER OF COMMERCE OF THE U.S.A. 38756 CHAMBER OF COMMERCE OF THE U.S.A. 2010 second_quarter PHA H.R. 1346/S. 540, Medical Device Safety Act of 2009 H.R. 3590, Patient Protection and Affordable Care Act Agriculture, Dept of (USDA),Army, Dept of (Corps of Engineers),Commerce, Dept of (DOC),Commodity Futures Trading Commission (CFTC),Council on Environmental Quality (CEQ),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Reserve System,Federal Trade Commission (FTC),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Maritime Administration (MARAD),Natl Aeronautics & Space Administration (NASA),Natl Economic Council (NEC),Natl Institute of Standards & Technology (NIST),Natl Labor Relations Board (NLRB),Natl Security Council (NSC),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),State, Dept of (DOS),St. Lawrence Seaway Development Corporation,Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office   9480000 0 0 2010-07-20T08:36:35.797000-04:00
967831 RUBICON ADVISORS, LLC 0a42a425-2e48-474a-aed3-6fb2ef6de648 Q2 RUBICON ADVISORS, LLC 315091 OSMOTICA PHARMACEUTICALS 2010 second_quarter PHA FDA Citizen Petition Reform Affordable Healthcare Choices Act   35000   0 0 2010-07-20T08:36:54.573000-04:00
967916 CAPITOL STRATEGIES GROUP, LLC 0eb0b166-afc9-4ec8-97e2-fc3136e49db2 Q2 CAPITOL STRATEGIES GROUP, LLC 400462294 PHRMA (ON BEHALF OF WE WORK FOR HEALTH ) 2010 second_quarter PHA -The impact of medical innovation on the economy HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2010-07-20T08:49:06.413000-04:00
968191 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION cb4ed426-ebeb-4a35-b9d4-62913212a3b6 Q2 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2010 second_quarter PHA Issues related to methamphetamine precursor chemicals HR 759, S 882 - regarding the manufacturing and import of OTC drugs Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   1687444 0 0 2010-07-20T09:21:37.497000-04:00
968281 OMNICARE, INC. aea7b35c-53e3-4814-812b-d2eabd64e959 Q2 OMNICARE, INC. 321112 OMNICARE INC 2010 second_quarter PHA Issues related to controlled substances distribution and accountability in skilled nursing facilities Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   88000 0 0 2010-07-20T09:31:57.577000-04:00
968349 DLA PIPER LLP (US) be4d63eb-be9e-4b15-9fe4-df7be408580f Q2 DLA PIPER LLP (US) 76855 SANOFI PASTEUR 2010 second_quarter PHA Pandemic influenza, vaccine-related issues. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2010-07-20T09:37:56.450000-04:00
968406 340B HEALTH 2727e376-4628-4e29-a227-b90076a6f6dc Q2 340B HEALTH 316434 340B HEALTH 2010 second_quarter PHA S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   191519 0 0 2010-07-20T09:42:12.523000-04:00
968525 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 87ce1c44-4c58-48c5-a4fc-2977fc77cfbe Q2 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2010 second_quarter PHA H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Reconciliation Act of 2010 H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   420000 0 0 2010-07-20T09:47:17.813000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2392.202ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API